Roger Crystal, Chief Executive Officer, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 3,475 shares at $6.99 ($24K) on 2017-01-17, disclosed to the SEC on 2017-01-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OPNT | SELL | 2023-01-05 | $203K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |